RespiVent Dosepack DF and Trastuzumab and Hyaluronidase
Determining the interaction of RespiVent Dosepack DF and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlorpheniramine / methscopolamine
Brand name:
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- RespiVent Dosepack DF-Trastuzumab Injection (Intravenous)
- RespiVent Dosepack DF-Trastuzumab Intravenous
- RespiVent Dosepack DF-Trastuzumab-anns
- RespiVent Dosepack DF-Trastuzumab-dkst
- RespiVent Dosepack DF-Trastuzumab-dkst Intravenous
- RespiVent Dosepack DF-Trasylol
- Trastuzumab and Hyaluronidase-Restall
- Trastuzumab and Hyaluronidase-Restoril
- Trastuzumab and Hyaluronidase-Retacrit
- Trastuzumab and Hyaluronidase-Retapamulin
- Trastuzumab and Hyaluronidase-Retapamulin topical
- Trastuzumab and Hyaluronidase-Retapamulin Topical application